Publication | Closed Access
A prospective study of neoadjuvant pembrolizumab plus chemotherapy for resectable esophageal squamous cell carcinoma: The Keystone-001 trial
34
Citations
45
References
2024
Year
Surgical OncologyEsophageal CancerGastrointestinal OncologyMedicinePathologyNeoadjuvant PembrolizumabKeystone-001 TrialProspective StudyCancer TreatmentOncologyRadiation Oncology
| Year | Citations | |
|---|---|---|
Page 1
Page 1